Pacific Biosciences of California 주식 주식분석 | 주식가격 | 뉴스 | PACB | US69404D1081 | A1C3EQ

날짜	Pacific Biosciences of California 주식 가격
	1.62 undefined
	1.57 undefined
	1.60 undefined
	1.86 undefined
	2.20 undefined
	2.21 undefined
	2.46 undefined
	2.30 undefined
	2.45 undefined
	2.65 undefined
	2.55 undefined
	2.51 undefined
	2.44 undefined
	2.17 undefined
	2.16 undefined
	2.06 undefined
	1.84 undefined
	1.77 undefined
	1.72 undefined
	1.75 undefined
	1.80 undefined
	1.84 undefined

날짜	Pacific Biosciences of California 매출	Pacific Biosciences of California EBIT	Pacific Biosciences of California 이익
2029e	612.05 백만 undefined	0 undefined	-8.34 백만 undefined
2028e	441.02 백만 undefined	-73.01 백만 undefined	-83.39 백만 undefined
2027e	386.64 백만 undefined	-121.81 백만 undefined	-105.63 백만 undefined
2026e	272.54 백만 undefined	-152.87 백만 undefined	-143.29 백만 undefined
2025e	212.3 백만 undefined	-200.57 백만 undefined	-189.26 백만 undefined
2024e	168.65 백만 undefined	-344.23 백만 undefined	-354.55 백만 undefined
2023	200.52 백만 undefined	-321.99 백만 undefined	-306.74 백만 undefined
2022	128.3 백만 undefined	-303.5 백만 undefined	-314.2 백만 undefined
2021	130.5 백만 undefined	-179.3 백만 undefined	-181.2 백만 undefined
2020	78.9 백만 undefined	-104.4 백만 undefined	29.4 백만 undefined
2019	90.9 백만 undefined	-100.5 백만 undefined	-84.1 백만 undefined
2018	78.6 백만 undefined	-101 백만 undefined	-102.6 백만 undefined
2017	93.5 백만 undefined	-89.8 백만 undefined	-92.2 백만 undefined
2016	90.7 백만 undefined	-71.2 백만 undefined	-74.4 백만 undefined
2015	92.8 백만 undefined	-52.1 백만 undefined	-31.7 백만 undefined
2014	60.6 백만 undefined	-62.9 백만 undefined	-66.2 백만 undefined
2013	28.2 백만 undefined	-77.5 백만 undefined	-79.3 백만 undefined
2012	26 백만 undefined	-94.3 백만 undefined	-94.5 백만 undefined
2011	33.9 백만 undefined	-109.8 백만 undefined	-109.4 백만 undefined
2010	1.7 백만 undefined	-140.2 백만 undefined	-140.2 백만 undefined
2009	100,000 undefined	-88.1 백만 undefined	-87.7 백만 undefined
2008	900,000 undefined	-44.8 백만 undefined	-43.8 백만 undefined
2007	2.2 백만 undefined	-23.4 백만 undefined	-21.5 백만 undefined
2006	2 백만 undefined	-11.9 백만 undefined	-11.7 백만 undefined
2005	1.4 백만 undefined	-10.9 백만 undefined	-10.9 백만 undefined

	매출	EBIT	이익
2005	1.4 백만 USD	-10.9 백만 USD	-10.9 백만 USD
2006	2 백만 USD	-11.9 백만 USD	-11.7 백만 USD
2007	2.2 백만 USD	-23.4 백만 USD	-21.5 백만 USD
2008	900,000 USD	-44.8 백만 USD	-43.8 백만 USD
2009	100,000 USD	-88.1 백만 USD	-87.7 백만 USD
2010	1.7 백만 USD	-140.2 백만 USD	-140.2 백만 USD
2011	33.9 백만 USD	-109.8 백만 USD	-109.4 백만 USD
2012	26 백만 USD	-94.3 백만 USD	-94.5 백만 USD
2013	28.2 백만 USD	-77.5 백만 USD	-79.3 백만 USD
2014	60.6 백만 USD	-62.9 백만 USD	-66.2 백만 USD
2015	92.8 백만 USD	-52.1 백만 USD	-31.7 백만 USD
2016	90.7 백만 USD	-71.2 백만 USD	-74.4 백만 USD
2017	93.5 백만 USD	-89.8 백만 USD	-92.2 백만 USD
2018	78.6 백만 USD	-101 백만 USD	-102.6 백만 USD
2019	90.9 백만 USD	-100.5 백만 USD	-84.1 백만 USD
2020	78.9 백만 USD	-104.4 백만 USD	29.4 백만 USD
2021	130.5 백만 USD	-179.3 백만 USD	-181.2 백만 USD
2022	128.3 백만 USD	-303.5 백만 USD	-314.2 백만 USD
2023	200.52 백만 USD	-321.99 백만 USD	-306.74 백만 USD
2024e	168.65 백만 USD	-344.23 백만 USD	-354.55 백만 USD
2025e	212.3 백만 USD	-200.57 백만 USD	-189.26 백만 USD
2026e	272.54 백만 USD	-152.87 백만 USD	-143.29 백만 USD
2027e	386.64 백만 USD	-121.81 백만 USD	-105.63 백만 USD
2028e	441.02 백만 USD	-73.01 백만 USD	-83.39 백만 USD
2029e	612.05 백만 USD	0 USD	-8.34 백만 USD

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.11	0.09	0.28	0.18	0.1	0.11	0.1	0.08	0.07	0.06	0.1	0.05	0.32	1.04	0.77	0.63
0	0	0.3	4.6	2.8	2.7	3.4	5.2	11.4	13.4	8.6	15.3	16.8	24.2	18.8	36.62
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	6.9	15.5	9.6	10.1	11.3	11	15.6	23.1	17.9	13.3	14.2	24.6	50.4	56.68
0.9	1	2.2	2.1	2	1.1	1.7	12.1	10	2.2	2.8	3.4	5.7	7.9	10.6	17.34
0.11	0.09	0.29	0.2	0.11	0.13	0.12	0.11	0.11	0.1	0.13	0.08	0.36	1.1	0.85	0.74
6	7.1	12.3	18.4	14.3	9.2	6.6	8.5	14.6	37.9	34.1	62.9	54.9	79.1	81.3	69.03
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	411	410.2	456.98
0	0	0	0	0	0	0	0	0	0	0	0	0	410	410	462.26
0.2	0.2	0.3	0.3	0.4	0.5	0.2	12	14.3	4.5	4.5	4	3.5	5.8	13.5	15.7
0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.02	0.03	0.04	0.04	0.07	0.06	0.91	0.92	1
0.11	0.1	0.31	0.22	0.13	0.14	0.12	0.13	0.14	0.14	0.17	0.15	0.41	2.01	1.77	1.75

201.1	269.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.27
0.01	0.01	0.61	0.63	0.65	0.68	0.74	0.79	0.87	0.97	1.1	1.12	1.37	2.01	2.1	2.54
-104.3	-192	-332.2	-441.6	-536	-615.3	-681.5	-713.2	-787.5	-879.7	-982.1	-1,066.2	-1,036.9	-1,218.1	-1,532.3	-1,839.08
0	0	0	100	0	0	0	0	0	0	0	0	100	-1,100	-4,800	219
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
107.7	92	279.9	191.5	109.4	69.2	54.9	73.5	84.7	86.2	114.2	55	335.5	790.9	562.9	701.3
1.8	5.8	9.5	4.7	3	1.7	5.6	4.7	8.4	9.1	6.7	8.4	3.6	11	12	15.06
1.1	2.1	6.2	7.2	5.8	7.9	11.4	15.6	16.6	12.6	12.8	17.1	21.7	44	41.5	55.3
0.5	0.5	5.1	7.3	5.7	12.9	14.4	17.9	8.8	6.9	7.3	7.8	13.2	16.7	208	24.18
1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0.1	0.1	0.2	0	0	0	0	0	0	15.9	0	0	1.8	0.49
4.7	8.4	20.9	19.3	14.7	22.5	31.4	38.2	33.8	28.6	26.8	49.2	38.5	71.7	263.3	95.03
0	0	2.9	2.8	0	13.3	14.1	14.9	16.1	13.6	14.7	0	0	896.1	897.2	892.74
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.7	0.7	2.1	4.7	5.6	31.1	24	4.4	3.3	15.7	14.7	43.9	40	248.2	43.7	56.94
0	0	0.01	0.01	0.01	0.04	0.04	0.02	0.02	0.03	0.03	0.04	0.04	1.14	0.94	0.95
0.01	0.01	0.03	0.03	0.02	0.07	0.07	0.06	0.05	0.06	0.06	0.09	0.08	1.22	1.2	1.04
0.11	0.1	0.31	0.22	0.13	0.14	0.12	0.13	0.14	0.14	0.17	0.15	0.41	2.01	1.77	1.75

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-21	-43	-87	-140	-109	-94	-79	-66	-31	-74	-92	-102	-84	29	-181	-314	-306
1	2	4	5	5	6	5	4	3	3	8	7	7	6	7	10	19
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-93	0	-11
1	0	4	2	-12	1	33	0	-31	-18	-6	5	-3	-2	21	-53	-58
3	4	7	19	24	19	19	21	25	40	42	46	17	3	208	173	170
0	0	0	0	0	0	1	1	1	1	1	1	1	0	6	14	15
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-16	-38	-74	-122	-102	-76	-29	-51	-47	-67	-67	-66	-78	19	-111	-263	-259
-3	-5	-5	-5	-9	-1	0	-1	-3	-8	-10	-1	-2	-1	-5	-16	-8
-18	-10	18	-138	6	61	-33	19	8	-14	-1	-38	62	-219	-678	116	4
-15	-4	23	-132	15	63	-32	21	11	-6	8	-36	64	-218	-672	133	13
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-1	0	0	0	19	0	0	0	-4	0	0	-16	895	-1	-1
0	120	68	318	7	2	23	41	36	65	73	107	8	233	326	11	204
0	0.12	0.07	0.32	0.01	0	0.04	0.04	0.04	0.07	0.07	0.11	0.03	0.25	1.17	0.01	0.11
0	0	0	0	0	0	0	0	0	0	0	0	18	34	-52	0	-93
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-35	71	10	58	-88	-12	-20	10	-2	-16	0	2	10	52	379	-137	-145
-19.78	-44	-80.02	-127.26	-112.25	-78.52	-30.74	-53.08	-50.9	-76.14	-77.95	-68.28	-81.15	18.46	-117.11	-280.14	-268.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Pacific Biosciences of California 브루토마진	Pacific Biosciences of California 이익 마진	Pacific Biosciences of California EBIT-마진	Pacific Biosciences of California 이익 마진
2029e	28.03 %	0 %	-1.36 %
2028e	28.03 %	-16.55 %	-18.91 %
2027e	28.03 %	-31.5 %	-27.32 %
2026e	28.03 %	-56.09 %	-52.57 %
2025e	28.03 %	-94.47 %	-89.15 %
2024e	28.03 %	-204.11 %	-210.23 %
2023	28.03 %	-160.58 %	-152.97 %
2022	41.08 %	-236.55 %	-244.89 %
2021	45.13 %	-137.39 %	-138.85 %
2020	41.32 %	-132.32 %	37.26 %
2019	38.06 %	-110.56 %	-92.52 %
2018	31.93 %	-128.5 %	-130.53 %
2017	37.11 %	-96.04 %	-98.61 %
2016	48.73 %	-78.5 %	-82.03 %
2015	57.65 %	-56.14 %	-34.16 %
2014	38.61 %	-103.8 %	-109.24 %
2013	22.7 %	-274.82 %	-281.21 %
2012	3.46 %	-362.69 %	-363.46 %
2011	38.35 %	-323.89 %	-322.71 %
2010	100 %	-8,247.06 %	-8,247.06 %
2009	100 %	-88,100 %	-87,699.99 %
2008	28.03 %	-4,977.78 %	-4,866.67 %
2007	28.03 %	-1,063.64 %	-977.27 %
2006	28.03 %	-595 %	-585 %
2005	28.03 %	-778.57 %	-778.57 %

	브루토마진	EBIT-마진	이익 마진
2005	28.03 %	-778.57 %	-778.57 %
2006	28.03 %	-595 %	-585 %
2007	28.03 %	-1,063.64 %	-977.27 %
2008	28.03 %	-4,977.78 %	-4,866.67 %
2009	100 %	-88,100 %	-87,699.99 %
2010	100 %	-8,247.06 %	-8,247.06 %
2011	38.35 %	-323.89 %	-322.71 %
2012	3.46 %	-362.69 %	-363.46 %
2013	22.7 %	-274.82 %	-281.21 %
2014	38.61 %	-103.8 %	-109.24 %
2015	57.65 %	-56.14 %	-34.16 %
2016	48.73 %	-78.5 %	-82.03 %
2017	37.11 %	-96.04 %	-98.61 %
2018	31.93 %	-128.5 %	-130.53 %
2019	38.06 %	-110.56 %	-92.52 %
2020	41.32 %	-132.32 %	37.26 %
2021	45.13 %	-137.39 %	-138.85 %
2022	41.08 %	-236.55 %	-244.89 %
2023	28.03 %	-160.58 %	-152.97 %
2024e	28.03 %	-204.11 %	-210.23 %
2025e	28.03 %	-94.47 %	-89.15 %
2026e	28.03 %	-56.09 %	-52.57 %
2027e	28.03 %	-31.5 %	-27.32 %
2028e	28.03 %	-16.55 %	-18.91 %
2029e	28.03 %	0 %	-1.36 %

날짜	Pacific Biosciences of California 주당 매출	Pacific Biosciences of California EBIT 당 주식	Pacific Biosciences of California 주당 이익
2029e	2.25 undefined	0 undefined	-0.03 undefined
2028e	1.62 undefined	0 undefined	-0.31 undefined
2027e	1.42 undefined	0 undefined	-0.39 undefined
2026e	1 undefined	0 undefined	-0.53 undefined
2025e	0.78 undefined	0 undefined	-0.69 undefined
2024e	0.62 undefined	0 undefined	-1.3 undefined
2023	0.79 undefined	-1.27 undefined	-1.21 undefined
2022	0.57 undefined	-1.35 undefined	-1.4 undefined
2021	0.64 undefined	-0.88 undefined	-0.89 undefined
2020	0.45 undefined	-0.6 undefined	0.17 undefined
2019	0.6 undefined	-0.66 undefined	-0.55 undefined
2018	0.58 undefined	-0.75 undefined	-0.76 undefined
2017	0.88 undefined	-0.85 undefined	-0.87 undefined
2016	1.02 undefined	-0.8 undefined	-0.84 undefined
2015	1.23 undefined	-0.69 undefined	-0.42 undefined
2014	0.86 undefined	-0.89 undefined	-0.94 undefined
2013	0.45 undefined	-1.23 undefined	-1.26 undefined
2012	0.47 undefined	-1.69 undefined	-1.7 undefined
2011	0.63 undefined	-2.04 undefined	-2.03 undefined
2010	0.03 undefined	-2.65 undefined	-2.65 undefined
2009	0 undefined	-1.76 undefined	-1.75 undefined
2008	0.02 undefined	-0.89 undefined	-0.87 undefined
2007	0.04 undefined	-0.47 undefined	-0.43 undefined
2006	0.04 undefined	-0.24 undefined	-0.23 undefined
2005	0.03 undefined	-0.22 undefined	-0.22 undefined

	주당 매출	EBIT 당 주식	주당 이익
2005	0.03 USD	-0.22 USD	-0.22 USD
2006	0.04 USD	-0.24 USD	-0.23 USD
2007	0.04 USD	-0.47 USD	-0.43 USD
2008	0.02 USD	-0.89 USD	-0.87 USD
2009	0 USD	-1.76 USD	-1.75 USD
2010	0.03 USD	-2.65 USD	-2.65 USD
2011	0.63 USD	-2.04 USD	-2.03 USD
2012	0.47 USD	-1.69 USD	-1.7 USD
2013	0.45 USD	-1.23 USD	-1.26 USD
2014	0.86 USD	-0.89 USD	-0.94 USD
2015	1.23 USD	-0.69 USD	-0.42 USD
2016	1.02 USD	-0.8 USD	-0.84 USD
2017	0.88 USD	-0.85 USD	-0.87 USD
2018	0.58 USD	-0.75 USD	-0.76 USD
2019	0.6 USD	-0.66 USD	-0.55 USD
2020	0.45 USD	-0.6 USD	0.17 USD
2021	0.64 USD	-0.88 USD	-0.89 USD
2022	0.57 USD	-1.35 USD	-1.4 USD
2023	0.79 USD	-1.27 USD	-1.21 USD
2024e	0.62 USD	0 USD	-1.3 USD
2025e	0.78 USD	0 USD	-0.69 USD
2026e	1 USD	0 USD	-0.53 USD
2027e	1.42 USD	0 USD	-0.39 USD
2028e	1.62 USD	0 USD	-0.31 USD
2029e	2.25 USD	0 USD	-0.03 USD

Segmente	2020	2019	2018
Product	65.42 백만 USD	77.74 백만 USD	66.36 백만 USD
Instrument	34.28 백만 USD	45.13 백만 USD	-
Consumable	31.14 백만 USD	32.62 백만 USD	-
Service and Other	13.47 백만 USD	13.15 백만 USD	12.27 백만 USD

	Product	Instrument	Consumable	Service and Other
2018	66.36 백만 USD	0 USD	0 USD	12.27 백만 USD
2019	77.74 백만 USD	45.13 백만 USD	32.62 백만 USD	13.15 백만 USD
2020	65.42 백만 USD	34.28 백만 USD	31.14 백만 USD	13.47 백만 USD

날짜	Asia	Asia Pacific	Europe	North America	U [S]
2020	-	22.55 백만 USD	19.07 백만 USD	37.28 백만 USD	-
2019	-	26.61 백만 USD	19.6 백만 USD	44.68 백만 USD	-
2017	-	39.7 백만 USD	13.2 백만 USD	40.6 백만 USD	-
2016	19.9 백만 USD	-	20 백만 USD	50.8 백만 USD	-
2015	15 백만 USD	-	9 백만 USD	68.8 백만 USD	-
2014	15.7 백만 USD	-	10.1 백만 USD	-	34.8 백만 USD

	Asia	Asia Pacific	Europe	North America	U [S]
2014	15.7 백만 USD	0 USD	10.1 백만 USD	0 USD	34.8 백만 USD
2015	15 백만 USD	0 USD	9 백만 USD	68.8 백만 USD	0 USD
2016	19.9 백만 USD	0 USD	20 백만 USD	50.8 백만 USD	0 USD
2017	0 USD	39.7 백만 USD	13.2 백만 USD	40.6 백만 USD	0 USD
2019	0 USD	26.61 백만 USD	19.6 백만 USD	44.68 백만 USD	0 USD
2020	0 USD	22.55 백만 USD	19.07 백만 USD	37.28 백만 USD	0 USD

	주식 수량
2005	50.1 백만 Aktien
2006	50.1 백만 Aktien
2007	50.1 백만 Aktien
2008	50.1 백만 Aktien
2009	50.1 백만 Aktien
2010	52.9 백만 Aktien
2011	53.9 백만 Aktien
2012	55.7 백만 Aktien
2013	62.8 백만 Aktien
2014	70.5 백만 Aktien
2015	75.6 백만 Aktien
2016	89.1 백만 Aktien
2017	105.7 백만 Aktien
2018	135.1 백만 Aktien
2019	152.5 백만 Aktien
2020	175 백만 Aktien
2021	204.1 백만 Aktien
2022	224.6 백만 Aktien
2023	253.63 백만 Aktien
2024e	253.63 백만 Aktien
2025e	253.63 백만 Aktien
2026e	253.63 백만 Aktien
2027e	253.63 백만 Aktien
2028e	253.63 백만 Aktien
2029e	253.63 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.23	-0.17 (25.76 %)	2024 Q3
-0.24	-0.64 (-169.7 %)	2024 Q2
-0.28	-0.29 (-3.24 %)	2024 Q1
-0.29	-0.31 (-6.57 %)	2023 Q4
-0.33	-0.26 (22.32 %)	2023 Q3
-0.33	-0.28 (14.4 %)	2023 Q2
-0.34	-0.36 (-6.13 %)	2023 Q1
-0.37	-0.37 (-0.41 %)	2022 Q4
-0.34	-0.34 (-0.5 %)	2022 Q3
-0.33	-0.32 (2.97 %)	2022 Q2
-0.31	-0.37 (-17.65 %)	2022 Q1
-0.29	-0.31 (-7.27 %)	2021 Q4
-0.22	-0.23 (-3.65 %)	2021 Q3
-0.21	-0.21 (0.05 %)	2021 Q2
-0.47	-0.45 (3.68 %)	2021 Q1
0.32	0.37 (14.06 %)	2020 Q4
-0.14	-0.14 (-2.41 %)	2020 Q3
-0.18	-0.15 (18.3 %)	2020 Q2
-0.16	-0.21 (-30.68 %)	2020 Q1
-0.17	0 (100 %)	2019 Q4
-0.15	-0.19 (-24.18 %)	2019 Q3
-0.16	-0.16 (1.96 %)	2019 Q2
-0.16	-0.2 (-29.03 %)	2019 Q1
-0.14	-0.21 (-53.62 %)	2018 Q4
-0.16	-0.19 (-21.87 %)	2018 Q3
-0.17	-0.17 (0.82 %)	2018 Q2
-0.2	-0.2 (-2.3 %)	2018 Q1
-0.2	-0.18 (10.27 %)	2017 Q4
-0.2	-0.19 (6.08 %)	2017 Q3
-0.25	-0.26 (-4.75 %)	2017 Q2
-0.24	-0.24 (-0.42 %)	2017 Q1
-0.23	-0.21 (8.78 %)	2016 Q4
-0.21	-0.19 (7.54 %)	2016 Q3
-0.23	-0.21 (8.22 %)	2016 Q2
-0.25	-0.23 (8.59 %)	2016 Q1
-0.02	-0.02 (10.71 %)	2015 Q4
-0.27	-0.26 (4.9 %)	2015 Q3
-0.14	-0.16 (-14.04 %)	2015 Q2
-0.28	-0.27 (1.96 %)	2015 Q1
-0.27	-0.26 (1.96 %)	2014 Q4
-0.16	-0.13 (20.34 %)	2014 Q3
-0.28	-0.27 (3.74 %)	2014 Q2
-0.28	-0.28 (0.18 %)	2014 Q1
-0.28	-0.26 (6.98 %)	2013 Q4
-0.31	-0.28 (8.5 %)	2013 Q3
-0.36	-0.33 (8.61 %)	2013 Q2
-0.38	-0.37 (3.52 %)	2013 Q1
-0.38	-0.39 (-2.23 %)	2012 Q4
-0.44	-0.41 (6.95 %)	2012 Q3
-0.47	-0.4 (15.49 %)	2012 Q2
-0.48	-0.5 (-5.04 %)	2012 Q1
-0.51	-0.42 (17.65 %)	2011 Q4
-0.6	-0.45 (24.86 %)	2011 Q3
-0.63	-0.42 (33.72 %)	2011 Q2
-0.69	-0.66 (4.04 %)	2011 Q1
-0.92	-0.97 (-4.97 %)	2010 Q4

%-지분	이름	주식	변경
12.18671 %	ARK Investment Management LLC	33,212,454	-77,683
9.52191 %	The Vanguard Group, Inc.	25,950,072	-607,542
8.58324 %	Madrone Advisors, LLC	23,391,915	5,800,000
7.65234 %	BlackRock Institutional Trust Company, N.A.	20,854,927	1,525,727
6.14113 %	Edmond de Rothschild Asset Management (France) S.A.	16,736,420	6,229,133
4.63823 %	Nikko Asset Management Co., Ltd.	12,640,561	-183,824
3.25962 %	Jackson Square Partners, LLC	8,883,443	1,699,130
2.23934 %	Geode Capital Management, L.L.C.	6,102,872	460,093
2.17789 %	State Street Global Advisors (US)	5,935,390	166,503
2.12781 %	Mellon Investments Corporation	5,798,913	-1,522,894
1.69876 %	Millennium Management LLC	4,629,627	2,215,506
1.28426 %	Shimoda Holdings LLC	3,500,000	0
1.24390 %	Capital World Investors	3,390,000	0
1.24390 %	Capital Research Global Investors	3,390,000	0
1.02277 %	Morgan Stanley & Co. LLC	2,787,361	1,458,412
0.98080 %	Newton Investment Management North America, LLC	2,672,983	23,426
0.96605 %	VK Services, LLC	2,632,784	0
0.76197 %	Goldman Sachs & Company, Inc.	2,076,602	240,259
0.74245 %	Northern Trust Investments, Inc.	2,023,394	-35,196
0.71827 %	Charles Schwab Investment Management, Inc.	1,957,496	-30,023
0.67331 %	Goldman Sachs Asset Management, L.P.	1,834,959	1,489,484
0.62887 %	T. Rowe Price Associates, Inc.	1,713,866	-94,973
0.62543 %	Jane Street Capital, L.L.C.	1,704,491	1,183,680
0.62305 %	Soros Fund Management, L.L.C.	1,698,000	65,000
0.60379 %	D. E. Shaw & Co., L.P.	1,645,499	836,239
0.59124 %	Marshall Wace LLP	1,611,300	1,117,966
0.55074 %	BofA Global Research (US)	1,500,919	923,084
0.48183 %	Dimensional Fund Advisors, L.P.	1,313,137	-2,121,331
0.45825 %	BNY Mellon Asset Management	1,248,875	100,785
0.44532 %	Norges Bank Investment Management (NBIM)	1,213,637	-161,078
0.38009 %	Casdin Capital, LLC	1,035,859	0
0.36844 %	BNP Paribas Securities Corp. North America	1,004,115	-163,593
0.35138 %	Two Sigma Investments, LP	957,620	624,528
0.35027 %	Bourne Lent Asset Management Inc.	954,595	3,200
0.33717 %	HHLR Advisors, Ltd.	918,892	0
0.33178 %	Citadel Advisors LLC	904,201	-578,114
0.33029 %	Group One Trading, L.P.	900,144	706,229
0.30421 %	UBS Financial Services, Inc.	829,073	151,820
0.30346 %	Mirae Asset Global Investments (USA) LLC	827,033	-508,829
0.30006 %	Susquehanna International Group, LLP	817,761	288,145
0.29858 %	BlackRock Investment Management, LLC	813,728	102,938
0.29553 %	BlackRock Financial Management, Inc.	805,411	-1,324,758
0.29500 %	Senvest Management, LLC	803,954	109,400
0.29355 %	Koss-Olinger Consulting, LLC	800,000	0
0.27823 %	BlackRock Advisors (UK) Limited	758,261	1,260
0.26083 %	Vestmark Advisory Solutions, Inc	710,850	-224,439
0.25719 %	BlackRock Asset Management Ireland Limited	700,908	-85,968
0.23610 %	SEI Investments Management Corporation	643,436	-914,278
0.21865 %	GSA Capital Partners LLP	595,874	595,874
0.20758 %	Cathay Securities Investment Trust Co., Ltd.	565,725	430,083
0.19250 %	Squarepoint Capital LLP	524,608	524,608
0.17438 %	Schweizerische Nationalbank	475,246	0
0.17186 %	ArrowMark Colorado Holdings, LLC	468,382	0
0.16396 %	Federated MDTA LLC	446,851	446,851
0.16030 %	Rhumbline Advisers Ltd. Partnership	436,868	51,727
0.15864 %	Nordea Funds Oy	432,337	218,182
0.15526 %	Oracle Investment Management, Inc.	423,138	-932,888
0.15473 %	Northern Trust Global Investments	421,678	-3,425
0.14789 %	Ordonez (Kathleen P)	403,037	22,821
0.12569 %	AllianceBernstein L.P.	342,540	71,810
0.12515 %	Algert Global LLC	341,066	161,066
0.12513 %	Managed Account Advisors LLC	341,008	-500,482
0.12102 %	Manulife Investment Management (North America) Limited	329,815	15,567
0.10740 %	TD Asset Management Inc.	292,686	-240,814
0.10661 %	J.P. Morgan Securities LLC	290,536	-85,708
0.10375 %	Brookfield BHS Advisors LLC	282,763	15,179
0.10343 %	Assenagon Asset Management S.A.	281,887	-1,013,416
0.10072 %	Nan Fung Life Sciences	274,488	0
0.09914 %	Nuveen LLC	270,184	-388,564
0.09224 %	Legal & General Investment Management Ltd.	251,371	15,761
0.09173 %	Ersel Asset Management SGR S.p.A.	250,003	2
0.09136 %	Nordea Investment Management AB (Denmark)	248,977	-19,579
0.09055 %	BlackRock Investment Management (UK) Ltd.	246,763	59,955
0.08986 %	Barclays Bank PLC	244,897	-406,715
0.08856 %	Van (Oene Mark D)	241,364	-38,011
0.08847 %	California State Teachers Retirement System	241,104	-717
0.08634 %	Daiwa Asset Management Co., Ltd.	235,308	9,516
0.08524 %	UBS Fund Management (Switzerland) AG	232,309	-92,923
0.08269 %	T. Rowe Price International Ltd	225,368	78,825
0.08190 %	Mirador Capital Partners LP	223,212	161,818
0.08161 %	Brevan Howard Capital Management LP	222,403	182,434
0.08033 %	UBS Asset Management (Switzerland)	218,931	41,697
0.07706 %	Claresco Finance S.A.	210,000	30,000
0.07423 %	Farmer (Michele)	202,288	-5,275
0.07392 %	LPL Financial LLC	201,442	20,790
0.07375 %	Henry (Christian O)	200,979	-98,907
0.06965 %	Guggenheim Investments	189,824	-37,702
0.06823 %	Emerge Canada Inc	185,954	16,033
0.06423 %	Aperio Group, LLC	175,055	24,454
0.06206 %	State of Wisconsin Investment Board	169,138	-4,405
0.05981 %	Carret Asset Management, LLC	163,000	85,400
0.05674 %	Walleye Capital LLC	154,631	148,209
0.05657 %	MetLife Investment Management, LLC	154,159	32,858
0.05443 %	Invesco Capital Management LLC	148,333	17,096
0.05412 %	UBS Asset Management (UK) Ltd.	147,490	27,953
0.05400 %	Corebridge Financial Inc	147,163	147,163
0.05370 %	Dimensional Fund Advisors, Ltd.	146,340	0
0.05204 %	Benjamin F. Edwards & Company, Inc.	141,830	139,408
0.04954 %	Farallon Capital Management, L.L.C.	135,000	-3,637,452
0.04874 %	Mohr (Marshall L)	132,821	22,821

What values and corporate philosophy does Pacific Biosciences of California represent?

Pacific Biosciences of California Inc represents a commitment to advancing scientific research and innovation in the field of biological sciences. With a strong focus on genetic sequencing technology, Pacific Biosciences is driven by the mission to enable groundbreaking discoveries and provide valuable insights into the complexity of biological systems. The company's corporate philosophy revolves around delivering high-quality, accurate, and scalable sequencing solutions that empower researchers and drive advancements in areas such as personalized medicine, agriculture, and conservation. Pacific Biosciences of California Inc aligns its values with transparency, collaboration, and a dedication to pushing the boundaries of scientific understanding through state-of-the-art technology and research.

In which countries and regions is Pacific Biosciences of California primarily present?

Pacific Biosciences of California Inc is primarily present in the United States of America.

What significant milestones has the company Pacific Biosciences of California achieved?

Pacific Biosciences of California Inc has achieved several significant milestones. Firstly, the company pioneered and developed Single Molecule, Real-Time (SMRT) DNA sequencing technology, revolutionizing biological research and genomic analysis. Secondly, Pacific Biosciences launched its first commercial instrument, the PacBio RS II System, which enabled long-read sequencing with unmatched accuracy. Furthermore, the company introduced the Sequel System, delivering increased scalability, affordability, and more extensive applications. Pacific Biosciences partnered with various renowned research institutions, industry leaders, and government agencies to advance scientific discovery and genomics research worldwide. These accomplishments have positioned Pacific Biosciences of California Inc as a leading provider of innovative genomic solutions, empowering researchers and scientists in deciphering the complexities of biology.

What is the history and background of the company Pacific Biosciences of California?

Pacific Biosciences of California Inc is a leading biotechnology company headquartered in California. Established in 2004, the company focuses on developing innovative solutions for genetic research and targeted sequencing technologies. Pacific Biosciences of California Inc is known for its state-of-the-art DNA sequencing platforms, enabling an in-depth understanding of complex biological systems. With a strong commitment to advancing scientific knowledge, the company has made significant contributions to various fields, including genomics, personalized medicine, and evolutionary biology. Leveraging cutting-edge technology and a dedicated team of experts, Pacific Biosciences of California Inc continues to drive advancements in genetic research and provide valuable insights into the intricacies of life science.

Who are the main competitors of Pacific Biosciences of California in the market?

The main competitors of Pacific Biosciences of California Inc in the market include Illumina Inc., Thermo Fisher Scientific Inc., and Oxford Nanopore Technologies Ltd.

In which industries is Pacific Biosciences of California primarily active?

Pacific Biosciences of California Inc is primarily active in the biotechnology industry.

What is the business model of Pacific Biosciences of California?

The business model of Pacific Biosciences of California Inc is focused on enabling the use of SMRT Sequencing technology to advance scientific research and genomic understanding. The company develops and sells innovative sequencing systems that provide high-quality genetic data with a wide range of applications in areas such as human genetics, plant and animal sciences, and microbiology. Pacific Biosciences combines its proprietary technology with extensive customer support and collaboration to offer reliable sequencing solutions to academic institutions, government organizations, and pharmaceutical companies worldwide. With a strong emphasis on cutting-edge genomics, Pacific Biosciences aims to drive breakthrough discoveries and contribute to advancements in personalized medicine and agricultural biotechnology.

Pacific Biosciences of California 2024의 P/E 비율은 얼마입니까?

Pacific Biosciences of California의 P/E 비율은 -1.16입니다.

Pacific Biosciences of California 2024의 KUV는 얼마입니까?

Pacific Biosciences of California의 P/S 비율은 2.44입니다.

Pacific Biosciences of California의 AlleAktien 품질 점수는 얼마인가요?

Pacific Biosciences of California에 대한 AlleAktien 품질 점수는 6/10입니다.

Pacific Biosciences of California 2024의 매출은 얼마인가요?

예상되는 Pacific Biosciences of California 매출은 168.65 백만 USD입니다.

Pacific Biosciences of California 2024의 이익은 얼마인가요?

예상되는 Pacific Biosciences of California 이익은 -354.55 백만 USD입니다.

Pacific Biosciences of California은 무엇을 하나요?

Pacific Biosciences of California Inc. is a company specializing in the development and marketing of DNA sequencing systems. The company was founded in 2004 and is headquartered in Menlo Park, California. Pacific Biosciences' business model focuses on providing DNA sequencing technologies and services to research institutions, pharmaceutical, and biotech companies. The company offers a portfolio of DNA sequencing systems and services to meet the needs of its customers. The product range primarily includes the SMRT (Single-Molecule, Real-Time) Sequencing System, which can analyze single molecules in real time. The SMRT system enables the detection of DNA methylation patterns, RNA transcript variants, fusion genes, and structural variations that cannot be detected by conventional sequencing methods. In addition, Pacific Biosciences also provides various services to support its customers with DNA sequencing. These include sequencing services, data analysis and reporting, as well as training and technical support. The company also has partnerships with other pharmaceutical and biotech companies to support the development of diagnostics and drugs. However, Pacific Biosciences' business model also faces challenges. The competition in the sequencing industry is strong, with established companies like Illumina and Thermo Fisher already holding a large market share. Additionally, the high costs of the systems and services can deter potential customers. The market for DNA sequencing systems is also closely tied to the research market, which is dependent on household budgets that can fluctuate over time. Nevertheless, Pacific Biosciences has experienced strong growth as more research institutions and pharmaceutical and biotech companies seek more advanced methods of DNA sequencing. In recent years, the company has also formed partnerships with companies like Invitae and Agilent Technologies to expand its presence in the diagnostics industry and provide customers with a more comprehensive solution. In summary, Pacific Biosciences' business model is centered around providing DNA sequencing technologies and services. The company offers a variety of products and services to meet the needs of research institutions and pharmaceutical and biotech companies. Pacific Biosciences' escalation model has firmly established it in the industry, and the company is committed to continuously improving and expanding its offerings to remain at the forefront of DNA sequencing technology.

Pacific Biosciences of California 배당금은 얼마입니까?

Pacific Biosciences of California은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Pacific Biosciences of California이 얼마나 자주 배당을 지급하나요?

Pacific Biosciences of California의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Pacific Biosciences of California ISIN이 무엇입니까?

Pacific Biosciences of California의 ISIN은 US69404D1081입니다.

Pacific Biosciences of California WKN은 무엇인가요?

Pacific Biosciences of California의 WKN은 A1C3EQ입니다.

Pacific Biosciences of California 티커는 무엇인가요?

Pacific Biosciences of California의 티커는 PACB입니다.

Pacific Biosciences of California이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Pacific Biosciences of California은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Pacific Biosciences of California은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Pacific Biosciences of California의 배당 수익률은 얼마입니까?

Pacific Biosciences of California의 현재 배당 수익률은 입니다.

Pacific Biosciences of California의 배당금은 언제 지급되나요?

Pacific Biosciences of California은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Pacific Biosciences of California의 배당금은 얼마나 안전한가요?

Pacific Biosciences of California은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Pacific Biosciences of California의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Pacific Biosciences of California이(가) 속해 있는 섹터는 어디인가요?

Pacific Biosciences of California은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Pacific Biosciences of California kaufen, um die vorherige Dividende zu erhalten?

Pacific Biosciences of California의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Pacific Biosciences of California의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Pacific Biosciences of California의 2023년도 배당금은 얼마였습니까?

2023년에 Pacific Biosciences of California는 0 USD를 배당금으로 지급했습니다.

Pacific Biosciences of California는 어떤 화폐로 배당금을 지급하나요?

Pacific Biosciences of California의 배당금은 USD에 지급됩니다.

Scope 1 - 직접 방출
스코프 2 - 구매한 에너지로부터의 간접적인 배출
Scope 3 - 가치 창출 체인 내의 간접 배출
총 CO₂ 배출량
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Pacific Biosciences of California 티커
뒤셀도르프	P09.DU
프랑크푸르트	P09.F
뮌헨	P09.MU
NASDAQ	PACB

Pacific Biosciences of California 티커	Pacific Biosciences of California FIGI
PACB:US	BBG000QKXH20
PACB:UA	BBG001776S60
PACB:UC	BBG001776S79
PACB:UN	BBG001776S97
PACB:UP	BBG001776SB4
PACB:UB	BBG001776SD2
PACB:UM	BBG001776SG9
PACB:UX	BBG001776SH8
PACB:UD	BBG001776SP9
PACB:UW	BBG001776SS6
PACB:UF	BBG001776ST5
PACB:VY	BBG001776SV2
PACB:VJ	BBG001776SW1
PACB:VK	BBG001776SY9
P09:GR	BBG00188TWG2
P09:GF	BBG00188TWH1
P09:GD	BBG00188TWJ9
P09:GS	BBG00188TWL6
P09:GM	BBG00188TWM5
P09:GB	BBG00188TWN4
P09:TH	BBG00188VY66
P09:QT	BBG008B3NKN8
PACBEUR:EO	BBG008B8PQ89
PACBEUR:XH	BBG008B8PQC4
PACBEUR:XF	BBG008B8PQF1
PACBEUR:XE	BBG008B8PQH9
PACBEUR:XJ	BBG008B8PQJ7
PACBEUR:XL	BBG008B8PQK5
PACBEUR:XG	BBG008B8PQL4
PACBEUR:XO	BBG008B8PQM3
PACBEUR:XS	BBG008B8PQR8
PACBEUR:XA	BBG008B8PQS7
PACBEUR:E1	BBG008B8PQT6
PACBEUR:XT	BBG008B8PQV3
PACBEUR:XW	BBG008B8PQW2
PACBEUR:XU	BBG008B8PQX1
PACBEUR:XV	BBG008B8PQZ9
PACBEUR:EU	BBG008B8PR14
PACB:VF	BBG00DJGJ5Y6
PACBEUR:XX	BBG00JN8BS47
PACBUSD:X2	BBG00JRFF384
PACBUSD:XB	BBG00JRFF393
PACBUSD:XH	BBG00JRFF3C9
PACBUSD:XF	BBG00JRFF3F6
PACBUSD:XE	BBG00JRFF3H4
PACBUSD:XJ	BBG00JRFF3J2
PACBUSD:XL	BBG00JRFF3K0
PACBUSD:XG	BBG00JRFF3L9
PACBUSD:XO	BBG00JRFF3M8
PACBUSD:XS	BBG00JRFF3R3
PACBUSD:XA	BBG00JRFF3S2
PACBUSD:E1	BBG00JRFF3T1
PACBUSD:XT	BBG00JRFF3V8
PACBUSD:XW	BBG00JRFF3W7
PACBUSD:XU	BBG00JRFF3X6
PACBUSD:XV	BBG00JRFF3Y5
PACBUSD:XM	BBG00JRFF3Z4
PACBUSD:XQ	BBG00JRFF419
PACBUSD:XX	BBG00JRFF428
PACBUSD:XZ	BBG00JRFF437
PACBUSD:EU	BBG00JRFF455
PACBGBP:XS	BBG00KWXGM56
PACBGBP:XH	BBG00KWXGM83
PACBGBP:XF	BBG00KWXGMB9
PACBGBP:XE	BBG00KWXGMD7
PACBGBP:XJ	BBG00KWXGMF5
PACBGBP:XL	BBG00KWXGMG4
PACBGBP:XG	BBG00KWXGMH3
PACBGBP:XO	BBG00KWXGMJ1
PACBGBP:XA	BBG00KWXGMN6
PACBGBP:E1	BBG00KWXGMP4
PACBGBP:XT	BBG00KWXGMQ3
PACBGBP:XW	BBG00KWXGMR2
PACBGBP:XU	BBG00KWXGMS1
PACBGBP:XV	BBG00KWXGMT0
PACBGBP:XM	BBG00KWXGMV7
PACBGBP:XQ	BBG00KWXGMX5
PACBGBP:XX	BBG00KWXGMY4
PACBGBP:XZ	BBG00KWXGMZ3
PACBGBP:EU	BBG00KWXGN18
PACBN:PO	BBG00MK1HW98
PACBN:L3	BBG00MK1HZX4
PACBN:B3	BBG00MK1J130
PACB:VG	BBG00X1NT637
PACB:VP	BBG00X1S7Q45
PACBN:L1	BBG00Y92JYP9
P09:GZ	BBG01357XF01
P09:LA	BBG018H947L0
P09:LU	BBG018J2S8G1

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
1	2	2	0	0	1	33	26	28	60	92	90	93	78	90	78	130	128	200	168	212	272	386	441	612
-	100.00	-	-	-	-	3,200.00	-21.21	7.69	114.29	53.33	-2.17	3.33	-16.13	15.38	-13.33	66.67	-1.54	56.25	-16.00	26.19	28.30	41.91	14.25	38.78
5,600.00	2,800.00	2,800.00	-	-	100.00	39.39	215.38	21.43	38.33	57.61	48.89	36.56	32.05	37.78	41.03	44.62	40.63	28.00	33.33	26.42	20.59	14.51	12.70	9.15
0	0	0	0	0	1	13	0	6	23	53	44	34	25	34	32	58	52	56	0	0	0	0	0	0
-10	-11	-21	-43	-87	-140	-109	-94	-79	-66	-31	-74	-92	-102	-84	29	-181	-314	-306	-354	-189	-143	-105	-83	-8
-	10.00	90.91	104.76	102.33	60.92	-22.14	-13.76	-15.96	-16.46	-53.03	138.71	24.32	10.87	-17.65	-134.52	-724.14	73.48	-2.55	15.69	-46.61	-24.34	-26.57	-20.95	-90.36
50.1	50.1	50.1	50.1	50.1	52.9	53.9	55.7	62.8	70.5	75.6	89.1	105.7	135.1	152.5	175	204.1	224.6	253.63	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커PACB

ISINUS69404D1081

WKNA1C3EQ

Pacific Biosciences of California 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Pacific Biosciences of California 주가 이력

Pacific Biosciences of California 주식 매출, EBIT, 이익 US69404D1081 · A1C3EQ

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Pacific Biosciences of California 매출, 이익 및 EBIT 역사

Pacific Biosciences of California 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Pacific Biosciences of California 주식 마진 US69404D1081 · A1C3EQ

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Pacific Biosciences of California 마진 역사

Pacific Biosciences of California 주식 매출, EBIT, 주당 순이익 US69404D1081 · A1C3EQ

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Pacific Biosciences of California 매출, 이익 및 EBIT 주당 역사

Pacific Biosciences of California 주식 및 주식 분석

Pacific Biosciences of California 매출 세분화 US69404D1081 · A1C3EQ

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Pacific Biosciences of California 매출 세분화

Pacific Biosciences of California 지역별 매출 US69404D1081 · A1C3EQ

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

Pacific Biosciences of California 매출 세분화

한눈에 과소평가된 주식을 인식하세요.

Pacific Biosciences of California Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Pacific Biosciences of California 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Pacific Biosciences of California 주식 수량 US69404D1081 · A1C3EQ

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

티커
PACB

ISIN
US69404D1081

WKN
A1C3EQ